Bharat Biotech gets DGCI nod for intranasal Covid booster doses
New Delhi, Jan 28: The Drugs Controller General of India (DCGI) has given its approval to Bharat Biotech for trials of its intranasal Covid booster dose in India. The trials will be done at 9 different sites.
Source: India News, India Breaking News, Latest news headlines in India – Oneindia News